OPK - OPKO Health Inc Sotuvning sof marjinal rentabelligi

OPKO Health Inc (OPK) - korporativ logo

Sof marja dinamikasi OPKO Health, Inc. (OPK) kompaniyasining moliyaviy barqarorligini namoyish etadi, bunda joriy qiymat -29.50 darajasida turibdi. Muntazam tekshiruvlar va patent huquqlari orqali barqaror daromad shakllantirilmoqda. Kirishning yuqori to'siqlari va sug'urta tolerantligi kompaniyaning asosiy ishtirokchi sifatidagi maqomini ta'minlaydi. Biznes hozirda foydani yirik tarmoqlarning bosimidan himoya qilish uchun noyob testlarni joriy etish orqali o'z laboratoriya tarmog'ini optimallashtirmoqda.

OPKO Health Corp. (OPK) - Sof marja 04.07.2022dan 19.11.2026gacha

OPKO Health, Inc. (OPK) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental baholanishi:OPKO Health - OPK
OPKO Health Corp. ishlab chiqargan mahsulot

BioReference tarmog'ining optimallashtirilishi va Rayaldee mahsulotining tijoratlashtirilishi OPKO Health, Inc. (OPK) kompaniyasining joriy operatsion samaradorligini ta'minlab, daromadlarni haqiqiy foydaga aylantirmoqda. Daromadning har bir birligi uchun sof marjani tahlil qilish orqali investor barcha xarajatlardan keyin qolgan foyda ulushini baholaydi, bu esa joriy rentabellikni tarixiy sikl bilan solishtirish imkonini beradi va o'zgaruvchan makroiqtisodiy muhitda aktivlarning haddan tashqari qimmat baholanishining oldini oladi.

OPKO Health, Inc. kimlar bilan raqobatlashadi

A (Agilent Technologies) - Sof foyda bo'yicha sotuv rentabelligi|DGX: Kompaniyaning sof rentabelligi|Sof marja Illumina Platform|EXAS (Exact Sciences) - Kompaniyaning sof rentabelligi|Sof foyda bo'yicha sotuv rentabelligi RVTY (PerkinElmer)|Bio-Rad - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi NNNN (Anbio)|Sof foyda normasi SHC|QDEL - Sof marja|Kompaniya sotuv marjasi CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Sof marja|Sof foyda bo'yicha marjinallik Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - Sotuvning sof marjinal rentabelligi|Cytek Biosciences (CTKB) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi OSUR|Exagen - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Sof marja|prenetics.com - Sotuvning sof marjinal rentabelligi|Insight Molecular Diagnostics, Inc. (IMDX) - Sof foyda bo'yicha sotuv rentabelligi|TRIB: Sotuvning sof marjinal rentabelligi|ProPhase - Sof foyda normasi|Sof marja ainos.com|CODX: Sof foyda normasi|Sof marja HeartSciences (HSCS)|Sof foyda bo'yicha sotuv rentabelligi Biomerica Inc. BMRA|Sotuvning sof marjinal rentabelligi CDIO (Cardio Diagnostics)|ONCO - Sof foyda bo'yicha sotuv rentabelligi|VRAX: Sof foyda bo'yicha sotuv rentabelligi|bluejaydx.com (BJDX) - Sof foyda bo'yicha sotuv rentabelligi|AWH: Sotuvning sof marjinal rentabelligi|AXDX: Kompaniyaning sof rentabelligi|CNTG (CENTOGENE N.V.) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Enzo Biochem, Inc. (ENZ)|FRES - Sof foyda marjasi|Genetic Technologies Limited (GENE) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi ME (23andme.com)|Psychemedics Corp. (PMD) - Sof marja